HITIQ Limited (ASX:HIQ)
Australia · Delayed Price · Currency is AUD 0.0170
+0.0010 (6.25%)
At close: Jan 22, 2026
HITIQ Revenue
In the fiscal year ending June 30, 2025, HITIQ had annual revenue of 2.01M AUD, down -57.57%. HITIQ had revenue of 984.21K in the half year ending June 30, 2025, with 97.62% growth.
Revenue
2.01M
Revenue Growth
-57.57%
P/S Ratio
4.48
Revenue / Employee
n/a
Employees
25
Market Cap
9.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.01M | -2.73M | -57.57% |
| Jun 30, 2024 | 4.75M | 1.75M | 58.30% |
| Jun 30, 2023 | 3.00M | 1.36M | 83.20% |
| Jun 30, 2022 | 1.64M | 1.23M | 302.64% |
| Jun 30, 2021 | 406.68K | -603.42K | -59.74% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |